Beroni Group Limited Approval for R&D Rebate for Anti-Cancer Drug PENAO

Sydney, Australia (ABN Newswire) - Beroni Group (OTCMKTS:BNIGF) (NSX:BTG), an Australia-based biopharmaceutical enterprise, today announced that PENAO Pty Ltd, its majority-owned, Sydney-based anti-cancer drug development company, has been approved by the Australian government for the annual 43.5% R&D rebate of eligible expenditure.

The approval also includes R&D overseas activities so long as the total overseas expenditure claim over the life of the R&D activities is less than the expected total expenditure on the Australian R&D activities to which they are scientifically linked.

The PENAO drug manufacture is expected to complete in the first half of 2022. Raw materials have been procured, familiarization studies have been completed and optimization work is progressing well at Aurigene Pharmaceutical Services Ltd, India.

"Aurigene is delighted to partner with PENAO Pty Ltd. In the past 18 years of our work, a key therapy area has been anticancer drug discovery and clinical development. Our technical and infrastructure capabilities provide an integrated drug substance and drug product program for PENAO." said Ravi Venkataramanan, CEO of Aurigene Pharmaceutical Services Ltd, a wholly-owned subsidiary of Dr. Reddy's Laboratories Limited (BOM:500124) (NYSE:RDY).

"We are pleased to receive the Australian government's support for our R&D activities, and we hope that the annual rebate signals to investors the rigorous due diligence conducted by the Australian government and our commitment to develop the PENAO drug to potentially meet the unmet medical need of millions of cancer patients worldwide" said Jacky Zhang, CEO of Beroni Group.



About Beroni Group Limited:  

Beroni Group (NSX:BTG) (OTCMKTS:BNIGF) is an international biopharmaceutical enterprise dedicated to the innovation and commercialization of drugs and therapies to combat various global diseases such as cancer and infectious diseases. Its diversified portfolio is comprised of a US FDA approved virus diagnostic kit, an e-commerce platform for the sale of pharmaceutical products and a development pipeline targeting oncology and cell therapies. Beroni has operations in Australia, United States, China and Japan. To learn more about Beroni, please visit www.beronigroup.com.



Source:
Beroni Group Limited



Contact:
Dragon Gate Investment Partners LLC
Tel: +1(646)-801-2803
Email: BNIGF@dgipl.com

News Provided by ABN Newswire via QuoteMedia

The Conversation (0)
Gold bull on gold coins.

Assets and Acquisitions Drive Value Creation in a Strong Gold Market

Mining companies are leveraging today's robust gold market to invest in strategic infrastructure and resource expansion, as both strategies present significant potential to create shareholder value.

The current strong price environment for gold not only enhances the profitability of existing operations, but also makes new projects financially viable. As mining and exploration companies continue to optimise existing assets and pursue targeted acquisitions, the current landscape is providing investors with a compelling opportunity to enhance their portfolios.

Keep reading...Show less
Octava Minerals Limited

Yallalong Antimony and Byro REE Drill Programs Progressing as Planned

Octava Minerals Limited (ASX:OCT) (“Octava” or the “Company”), a Western Australia focused explorer of the new energy metals antimony, REE’s, Lithium and gold, is pleased to report that exploration drilling at its 100% owned Yallalong antimony project in the mid-west of Western Australia is on track and progressing as expected. In addition, the planned two metallurgical core drill holes are now complete, with samples on their way to Perth to undergo testwork in coming months.

Keep reading...Show less
Gold bars, ripped US$100 bills.

Gold's "Moneyness": Experts Debate Inflation, Dollar Dilemma and Future Highs

Moderated by Thom Calandra of the Calandra Report, the precious metals panel at this year's New Orleans Investment Conference featured several well-known gold analysts and market watchers.

Omar Ayales, Rich Checkan, Jeff Deist, Avi Gilburt and Dana Samuelson took the stage for a 35-minute discussion that began with a discussion of the monetary value of gold and Bitcoin, as well as the liquidity pros and cons of both.

For Deist, general counsel at Monetary Metals, it all comes down to a word he used frequently: “moneyness.”

Keep reading...Show less
Gold nugget on scale.

Northern Star to Grow Gold Portfolio with AU$5 Billion De Grey Mining Acquisition

Northern Star Resources (ASX:NST,OTC Pink:NESRF) said on Monday (December 2) that it has entered into a binding scheme implementation deed to acquire De Grey Mining (ASX:DEG,OTC Pink:DGMLF).

Under the deal, Northern Star will take ownership of of De Grey, as well as its flagship Hemi gold project.

De Grey shareholders will receive 0.119 new Northern Star shares for each De Grey share held at the record date for the scheme, which represents an implied offer price of AU$2.08 per De Grey share.

Keep reading...Show less

Latest Press Releases

Related News

×